Get started
ESSA Pharma Inc.EE

ESSA Pharma Inc.

1.54USDR
+0.01+0.65%
Last update at Mar 27, 20:00 GMT
USD
No tradesPre-market
See on Supercharts
Overview
Financials
News Ideas Discussions Technicals Forecast Seasonals Options

EPIX fundamentals

Key facts

Market capitalization‪68.36 M‬USD
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)−0.70USD
Founded2009
Employees (FY)35
CEODavid R. Parkinson
Websiteessapharma.com
About

ESSA Pharma, Inc. is a clinical stage pharmaceutical company. It engages in the business of developing small molecule drugs for the treatment of prostate cancer. The company was founded by Marianne D. Sadar and Raymond J. Andersen on January 6, 2009 and is headquartered in Vancouver, Canada.

Ownership
‪‪44.39 M‬‬
Free Float shares
‪‪41.72 M‬‬ (93.98%)
Closely held shares
‪‪2.67 M‬‬ (6.02%)
Free Float shares
‪‪41.72 M‬‬ (93.98%)
Closely held shares
‪‪2.67 M‬‬ (6.02%)
Capital structure
Market cap
‪‪68.36 M‬‬
Debt
‪‪305.04 K‬‬
Cash & equivalents
‪‪120.55 M‬‬
Enterprise value
‪‪−51.89 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪68.36 M‬‬
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
—
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
—
Valuation ratios
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25

Growth and Profitability

Company’s recent performance and margins

Performance
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪‪−10.00 M‬‬
‪‪−7.50 M‬‬
‪‪−5.00 M‬‬
‪‪−2.50 M‬‬
‪0.00‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−10.00 M‬‬
‪‪−7.50 M‬‬
‪‪−5.00 M‬‬
‪‪−2.50 M‬‬
‪0.00‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−10.00 M‬‬
‪‪−7.50 M‬‬
‪‪−5.00 M‬‬
‪‪−2.50 M‬‬
‪0.00‬

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
‪0.00‬
Actual
Estimate
Earnings
Next:May 13, 2025
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
‪−0.28‬
‪−0.21‬
‪−0.14‬
‪−0.07‬
‪0.00‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

EPIX does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪‪−40.00 M‬‬
‪0.00‬
‪‪40.00 M‬‬
‪‪80.00 M‬‬
‪‪120.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪35.00 M‬‬
‪‪70.00 M‬‬
‪‪105.00 M‬‬
‪‪140.00 M‬‬
Assets
Liabilities